Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149617 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 81
- Enrollment target
NCT00149617 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 81 participants.
The verdict
NCT00149617, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study will assess the effectiveness of a combination of buspirone and motivational interviewing therapy in the treatment of marijuana dependence.
Interventions
- DRUG Buspirone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00149617
The ClinicalTrials.gov registry entry for NCT00149617 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Buspirone is the first listed.
NCT00149617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00149617 about?
NCT00149617 is a clinical study titled "Effectiveness of Buspirone and Motivational Enhancement Therapy for the Treatment of Marijuana Dependence - 1". This study will assess the effectiveness of a combination of buspirone and motivational interviewing therapy in the treatment of marijuana dependence.
What is the current status of trial NCT00149617?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 81 participants. The study started on 2004-04. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00149617?
The interventions under investigation include: Buspirone (DRUG).
Who is sponsoring clinical trial NCT00149617?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.